Immunology

  1. The CXCR6/CXCL16 axis links inflamm-aging to disease severity in COVID-19 patients

    1. Daniel J. Payne
    2. Surita Dalal
    3. Richard Leach
    4. Richard Parker
    5. Stephen Griffin
    6. Clive S. McKimmie
    7. Graham P. Cook
    8. Stephen J. Richards
    9. Peter Hillmen
    10. Talha Munir
    11. Louise Arnold
    12. Kathryn Riley
    13. Claire McKinley
    14. Sandra Place
    15. Richard L. Baretto
    16. Darren J. Newton

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Resistance of endothelial cells to SARS-CoV-2 infection in vitro

    1. Blerina Ahmetaj-Shala
    2. Thomas P. Peacock
    3. Laury Baillon
    4. Olivia C. Swann
    5. Hime Gashaw
    6. Wendy S. Barclay
    7. Jane A. Mitchell

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19 disease in hamsters

    1. Qingmei Jia
    2. Helle Bielefeldt-Ohmann
    3. Rachel Maison
    4. Saša Masleša-Galić
    5. Richard Bowen
    6. Marcus A. Horwitz

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. T cell activation, highly armed cytotoxic cells and a sharp shift in monocytes CD300 receptors expression is characteristic of patients with severe COVID-19

    1. Olatz Zenarruzabeitia
    2. Gabirel Astarloa-Pando
    3. Iñigo Terrén
    4. Ane Orrantia
    5. Raquel Pérez-Garay
    6. Iratxe Seijas-Betolaza
    7. Javier Nieto-Arana
    8. Natale Imaz-Ayo
    9. Silvia Pérez-Fernández
    10. Eunate Arana-Arri
    11. Francisco Borrego

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. The landscape of antibody binding in SARS-CoV-2 infection

    1. Anna S. Heffron
    2. Sean J. McIlwain
    3. Maya F. Amjadi
    4. David A. Baker
    5. Saniya Khullar
    6. Ajay K. Sethi
    7. Ann C. Palmenberg
    8. Miriam A. Shelef
    9. David H. O’Connor
    10. Irene M. Ong

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library

    1. Benjamin N. Bell
    2. Abigail E. Powell
    3. Carlos Rodriguez
    4. Jennifer R. Cochran
    5. Peter S. Kim

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection

    1. Bryan E. Jones
    2. Patricia L. Brown-Augsburger
    3. Kizzmekia S. Corbett
    4. Kathryn Westendorf
    5. Julian Davies
    6. Thomas P. Cujec
    7. Christopher M. Wiethoff
    8. Jamie L. Blackbourne
    9. Beverly A. Heinz
    10. Denisa Foster
    11. Richard E. Higgs
    12. Deepa Balasubramaniam
    13. Lingshu Wang
    14. Roza Bidshahri
    15. Lucas Kraft
    16. Yuri Hwang
    17. Stefanie Žentelis
    18. Kevin R. Jepson
    19. Rodrigo Goya
    20. Maia A. Smith
    21. David W. Collins
    22. Samuel J. Hinshaw
    23. Sean A. Tycho
    24. Davide Pellacani
    25. Ping Xiang
    26. Krithika Muthuraman
    27. Solmaz Sobhanifar
    28. Marissa H. Piper
    29. Franz J. Triana
    30. Jorg Hendle
    31. Anna Pustilnik
    32. Andrew C. Adams
    33. Shawn J. Berens
    34. Ralph S. Baric
    35. David R. Martinez
    36. Robert W. Cross
    37. Thomas W. Geisbert
    38. Viktoriya Borisevich
    39. Olubukola Abiona
    40. Hayley M. Belli
    41. Maren de Vries
    42. Adil Mohamed
    43. Meike Dittmann
    44. Marie Samanovic
    45. Mark J. Mulligan
    46. Jory A. Goldsmith
    47. Ching-Lin Hsieh
    48. Nicole V. Johnson
    49. Daniel Wrapp
    50. Jason S. McLellan
    51. Bryan C. Barnhart
    52. Barney S. Graham
    53. John R. Mascola
    54. Carl L. Hansen
    55. Ester Falconer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Single-dose intranasal administration of AdCOVID elicits systemic and mucosal immunity against SARS-CoV-2 in mice

    1. Rodney G King
    2. Aaron Silva-Sanchez
    3. Jessica N. Peel
    4. Davide Botta
    5. Selene Meza-Perez
    6. S. Rameeza Allie
    7. Michael D. Schultz
    8. Mingyong Liu
    9. John E. Bradley
    10. Shihong Qiu
    11. Guang Yang
    12. Fen Zhou
    13. Esther Zumaquero
    14. Thomas S. Simpler
    15. Betty Mousseau
    16. John T. Killian
    17. Brittany Dean
    18. Qiao Shang
    19. Jennifer L. Tipper
    20. Christopher Risley
    21. Kevin S. Harrod
    22. Ray Feng
    23. Young Lee
    24. Bethlehem Shiberu
    25. Vyjayanthi Krishnan
    26. Isabelle Peguillet
    27. Jianfeng Zhang
    28. J. Todd Green
    29. Troy D. Randall
    30. Bertrand Georges
    31. Frances E. Lund
    32. Scot Roberts

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. CoVaccine HT™ adjuvant potentiates robust immune responses to recombinant SARS-CoV-2 Spike S1 immunisation

    1. Brien K. Haun
    2. Chih-Yun Lai
    3. Caitlin A. Williams
    4. Teri Ann Wong
    5. Michael M. Lieberman
    6. Laurent Pessaint
    7. Hanne Andersen-Elyard
    8. Axel T. Lehrer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro

    1. Mary Hongying Cheng
    2. Rebecca A. Porritt
    3. Magali Noval Rivas
    4. James M. Krieger
    5. Asli Beyza Ozdemir
    6. Gustavo Garcia
    7. Vaithilingaraja Arumugaswami
    8. Bettina C. Fries
    9. Moshe Arditi
    10. Ivet Bahar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 126 of 174 Next